NCT05402865View on ClinicalTrials.gov

A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone

CompletedOBSERVATIONAL
Enrollment

301

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

February 18, 2022

Conditions
Giant Cell Tumor of Bone
Interventions
DRUG

Denosumab

Denosumab, subcutaneous injection, specific usage to see the medical records. Non-denosumab, specific usage to see the medical records.

Trial Locations (3)

100035

Beijing Jishuitan Hospital, Beijing

100191

Peking University Third Hospital, Beijing

610044

West China Hospital of Sichuan University, Beijing

All Listed Sponsors
lead

Shanghai JMT-Bio Inc.

INDUSTRY

NCT05402865 - A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone | Biotech Hunter | Biotech Hunter